Each year, more than 1.8 million people receive a lung cancer diagnosis. Though research and treatment options have come a long way, there is still far more work to be done to stop the number one cancer killer. The Lung Cancer Registry was created for anyone who has been diagnosed with lung cancer to allow patients to be a part of the solution. The registry is a knowledge base for lung cancer researchers working to find medical treatments through data shared [...]
Dear Friends, It has been one week since we announced our merger forming the GO2 Foundation for Lung Cancer and shared how this new powerhouse will transform the future of lung cancer. We continue to be overwhelmed by the outpouring of support and enthusiasm and want to personally express our gratitude. Thank you to all the patients, survivors, caregivers, advocates, researchers, industry and public health leaders, who took the time to reinforce that we made a great decision that will [...]
On April 11, the U.S. Food and Drug Administration approved pembrolizumab (KEYTRUDA) as a first-line treatment for patients with advanced NSCLC who have a score of 1% or higher on the PD-L1 biomarker test. The approval was based on KEYNOTE-042 trial which demonstrated statistically significant OS improvements for those randomized to pembrolizumab compared with chemotherapy. Click here to read the full press release.
Priority Focus Renewed on Women’s Health Imperative – House and Senate Leaders Reintroduce Women and Lung Cancer Research and Preventive Services Act of 2019
GO2 Foundation for Lung Cancer hails bipartisan effort to accelerate progress to increase survivorship April 10, 2019 - Today the GO2 Foundation for Lung Cancer praises Senators Marco Rubio (R-FL), Dianne Feinstein (D-CA), Shelley Moore Capito (R-WV), and Joe Manchin (D-WV), and Representatives Brendan Boyle (D-PA), Brian Fitzpatrick (R-PA), Debbie Dingell (D-MI), and Suzanne Bonamici (D-OR) for elevating national attention to a women’s public health imperative by re-introducing the 2018 Senate and House bills (S. 2358 and H.R. 4897) as the Women [...]